Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis
- PMID: 3665680
- DOI: 10.1007/BF01296375
Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis
Abstract
Campylobacter pyloridis has been associated with antral gastritis and duodenal ulcer. To study the pathogenetic role of these organisms in duodenal ulcer, endoscopic biopsies, two from the first part of duodenum, four from antrum, and four from body and fundus, were taken before and after four weeks of cimetidine treatment (1.2 g/day) from 67 patients with active duodenal ulcer. The biopsies were examined for the presence and severity of any inflammation by two independent pathologists in the absence of any clinical information and for the occurrence and density of Campylobacter pyloridis by culture and Warthin-Starry stain. Before treatment, inflammation was present in 71.1, 100, and 25.8%, while the organisms were present in 34.3, 91.0, and 79.1% of the duodenal, antral, and fundal biopsies, respectively. With complete healing of duodenal ulcer, inflammation was present in 48.9, 98.2, and 30.2%, while the organisms were present in 25, 76.7, and 63.3% of the respective mucosae. With ulcer healing, duodenitis became significantly milder (P less than 0.05). With improvement of gastritis and duodenitis, there was no significant change in the occurrence and density of Campylobacter pyloridis. These findings indicate that healing of duodenal ulcer is not influenced by the presence of Campylobacter pyloridis, which is frequently found in the gastroduodenal mucosa of patients with duodenal ulcer, but does not appear to be associated with mucosal inflammation except in the antrum.
Similar articles
-
Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation.Gut. 1986 Oct;27(10):1132-7. doi: 10.1136/gut.27.10.1132. Gut. 1986. PMID: 3781324 Free PMC article.
-
Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings.Scand J Gastroenterol. 1987 Mar;22(2):219-24. doi: 10.3109/00365528708991883. Scand J Gastroenterol. 1987. PMID: 3576129
-
Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.Am J Med. 1989 Jun 9;86(6A):60-5. doi: 10.1016/0002-9343(89)90159-9. Am J Med. 1989. PMID: 2660558 Clinical Trial.
-
Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.J Infect Dis. 1990 Apr;161(4):626-33. doi: 10.1093/infdis/161.4.626. J Infect Dis. 1990. PMID: 2181029 Review.
-
[Has Campylobacter pylori infection any clinical relevance? Methodologic, epidemiologic and clinical studies].Orv Hetil. 1989 Nov 26;130(48):2563-8. Orv Hetil. 1989. PMID: 2689946 Review. Hungarian.
Cited by
-
Pathogenetic role of Helicobacter pylori in duodenal ulcer disease. Multivariate analysis of factors affecting relapse.Dig Dis Sci. 1991 Apr;36(4):424-30. doi: 10.1007/BF01298869. Dig Dis Sci. 1991. PMID: 2007359 Clinical Trial.
-
H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.Dig Dis Sci. 1999 Nov;44(11):2295-302. doi: 10.1023/a:1026669123593. Dig Dis Sci. 1999. PMID: 10573377
-
Treatment of Helicobacter pylori-associated gastroduodenal disease in children. Clinical evaluation of antisecretory vs antibacterial therapy.Dig Dis Sci. 1993 Jan;38(1):123-8. doi: 10.1007/BF01296783. Dig Dis Sci. 1993. PMID: 8093598
-
Campylobacter pylori and gastroduodenal disease.Clin Microbiol Rev. 1990 Jan;3(1):1-12. doi: 10.1128/CMR.3.1.1. Clin Microbiol Rev. 1990. PMID: 2404565 Free PMC article. Review.
-
Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy.Ann Gastroenterol. 2014;27(1):48-52. Ann Gastroenterol. 2014. PMID: 24714519 Free PMC article.